Run by TMC Innovation.
TMC Innovation's Accelerator for Cancer Therapeutics runs annual cohorts in Houston on what it calls a flexible model, with no fixed programme length published. It makes no investment, publishes no participation fee and takes no equity, welcoming everything from academic investigators to early-stage biotech companies; what it provides is grant-writing support for non-dilutive funding, computational chemistry resources, competitive intelligence and venture relationship development.
This programme has notes explaining its undisclosed figures, available in the full dataset.
Every figure above is taken from these pages, published by the programme or its parent organisation.
Compare all 2 TMC Innovation programmes.
Last verified 2026-09-06.